2014
DOI: 10.1016/j.lfs.2013.12.006
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac expression and atrial fibrillation-associated remodeling of K2P2.1 (TREK-1) K+ channels in a porcine model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
33
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 39 publications
1
33
0
Order By: Relevance
“…Our findings suggest (1) that downregulation of TREK‐1–associated β IV ‐spectrin occurs in specific cardiac disease states to promote SAN dysfunction and (2) that loss of TREK‐1 function promotes abnormal SAN cell excitability and pacemaking defects. Interestingly, our new data align with recent studies that have shown dramatic reduction in TREK‐1 in the right atrium during persistent atrial fibrillation in the pig, suggesting a broader role for TREK‐1 dysfunction in atrial arrhythmogenesis 36. It is interesting to note that αMHC‐ Kcnk2 f/f animals show mild bradycardia at rest despite an increase in SAN cell membrane excitability (increased AP firing rate).…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Our findings suggest (1) that downregulation of TREK‐1–associated β IV ‐spectrin occurs in specific cardiac disease states to promote SAN dysfunction and (2) that loss of TREK‐1 function promotes abnormal SAN cell excitability and pacemaking defects. Interestingly, our new data align with recent studies that have shown dramatic reduction in TREK‐1 in the right atrium during persistent atrial fibrillation in the pig, suggesting a broader role for TREK‐1 dysfunction in atrial arrhythmogenesis 36. It is interesting to note that αMHC‐ Kcnk2 f/f animals show mild bradycardia at rest despite an increase in SAN cell membrane excitability (increased AP firing rate).…”
Section: Discussionsupporting
confidence: 89%
“…TREK‐1 expression has been reported throughout all regions of the heart3, 8, 10, 36; however, few data are available on relative levels of expressed protein in SAN, atrium, and ventricle. TREK‐1 protein expression was assessed in different mouse heart regions to determine whether differential expression could contribute to the predominant SAN phenotypes observed in αMHC‐ Kcnk2 f/f mice.…”
Section: Resultsmentioning
confidence: 99%
“…Rapid electrical pacing of cultured cells in vitro or tissue in vivo is an established model of cardiac tachyarrhythmia that may induce electrophysiological remodeling similar to human findings [1,3,5,35,41,42]. In particular, tachypacing of HL-1 cells has been shown to cause action potential shortening [35].…”
Section: Tachypacing-associated Upregulation Of Kcnj5 Potassium Channmentioning
confidence: 99%
“…131 Whole cell currents exhibiting the characteristics of recombinant TREK-1 (including sensitivity to volatile anaesthetics, arachidonic acid, pH, internal acidification, and stretch) have been observed in atrial and ventricular myocytes of several species including rat, mouse and pig. 137, 142 …”
Section: Cardiac Sac: Molecular Candidatesmentioning
confidence: 99%
“…136 In keeping with this, several well-established anti-arrhythmic drugs, including lidocaine, mexiletine, propafenone, carvedilol, dronedarone, and vernakalant, inhibit TREK-1. 142 …”
Section: Cardiac Sac: Molecular Candidatesmentioning
confidence: 99%